ARTICLE | Company News
Caris Life Sciences, Threshold deal
October 31, 2016 7:00 AM UTC
Caris and Threshold partnered to develop a companion diagnostic for Threshold’s evofosfamide using Caris’ ADAPT biotargeting system. Evofosfamide is a hypoxia-activated cytotoxic 2-nitroimidazole prod...